The latest addition to WIT, Sergio Isola, has presented a poster with the first results of his PhD research at the 31st Annual Congress of the European Society of Gene and Cell Therapy that took place in Rome at the end of October, 2024.

Sergio is currently researching in gene editing strategy to develop a therapy for non-syndromic congenital hearing loss caused by the deficiency of a protein called Connexin 26, within the framework of the thesis work that is carrying out at the group of Gene Therapy for Rare Diseases at  CIMA-Unav.

The group was well represented at the congress, since Sergio was accompanied by other predoctoral students, as well as by his thesis supervisors, Gloria González-Aseguinolaza and Carmen Unzu. Sergio has participated in the category of Central nervous system and sensory diseases, with the poster titled 'AAV capsid discovery in the cochlea of non-human primates for precision gene medicine of congenital auditory indications'.

All of them have made interesting contributions to this annual event!!
Congratulations to all the team!!